E-post: annika [dot] dejmek [at] med [dot] lu [dot] se
(hämtat ur Lunds universitets publikationsdatabas)
- Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.
- Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: a secondary publication.
- Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.
- Comparison of NCL-hTERT antibody reactivity and telomere repeat amplification protocol in situ in effusions
- Lower proliferation rate in metastatic effusion mesothelial cells than in benign effusions.
- Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions
- No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden.
- The proliferation rates in mesothelial cells in effusions also containing metastatic cells are lower than in benign effusions
- Weak telomerase activity in malignant cells in metastatic serous effusions - Correlation to short survival time
- Telomere repeat amplification protocol (TRAP in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes
- The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion.
- Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis.